- Naranj Research Desk
KRYS — NASDAQ —
Current RSI of this stock is 68.18, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
MACD line has crossed the signal line from the below, generates bullish signal.
Based on our swing trading strategies for USA stocks, Krystal Biotech stock price target will be USD 200 - USD 203 in the next 12-14 trading sessions.
Krystal Biotech, Inc. is a biotechnology company that focuses on discovering, developing, and commercializing genetic medicines for rare diseases in the United States. The company’s current focus is on commercializing VYJUVEK for the treatment of dystrophic epidermolysis bullosa, as well as developing several other genetic medicines for various rare diseases. Founded in 2016, Krystal Biotech, Inc. is based in Pittsburgh, Pennsylvania.
KRYS — NASDAQ —
Current RSI of this stock is 68.18, which indicates the strength of buyers.
Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
MACD line has crossed the signal line from the below, generates bullish signal.
Based on our swing trading strategies for USA stocks, Krystal Biotech stock price target will be USD 200 - USD 203 in the next 12-14 trading sessions.